Results were announced from a phase 3 study evaluating an investigational intramuscular (IM) formulation of ibalizumab-uiyk for the treatment of heavily treatment-experienced adults with ...
The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks. The Food and Drug Administration (FDA) has approved Trogarzo ® ...
HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to a reduced mortality and improved life ...
An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...
More than 1 million Americans live with human immunodeficiency virus, or HIV, with tens of thousands of new diagnoses each year. But with earlier diagnoses and advances in treatment, HIV, the virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results